Lazard Asset Management’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,972
| Closed | -$75K | – | 2332 |
|
|
2025
Q1 | $75K | Buy |
18,972
+2
| +0% | +$8 | ﹤0.01% | 1893 |
|
|
2024
Q4 | $122K | Buy |
+18,970
| New | +$122K | ﹤0.01% | 1743 |
|
|
2023
Q1 | – | Sell |
-1,175
| Closed | -$11K | – | 2340 |
|
|
2022
Q4 | $11K | Sell |
1,175
-1,130
| -49% | -$10.6K | ﹤0.01% | 2187 |
|
|
2022
Q3 | $33K | Sell |
2,305
-4,250
| -65% | -$60.8K | ﹤0.01% | 1952 |
|
|
2022
Q2 | $70K | Buy |
+6,555
| New | +$70K | ﹤0.01% | 1662 |
|